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Abstract 
 
Introduction: The practice of Comprehensive Medication Management (CMM) is a poorly characterized intervention across the 
practice of pharmacy limiting its measurable impact on patient care. To address the inconsistent application of CMM in the primary 
care setting, our project set out to design and validate a CMM specific organizational capacity tool to assist clinicians working in 
primary care settings to better understand the structure and function supports needed to implement a new intervention in their 
setting.  
 
Methods: Organizational capacity concepts were identified through an informal literature review. Experts reviewed the concepts, 
sorted them into domains and designed questions from the identified domains. Seven reviewers were asked to score each concept 
on a scale from 1-4 based on three criteria: relevance, clarity and alignment. Scores provided from internal reviewers were 
evaluated using an adapted content validity process described by Rubio et al (2012). A panel of Key Opinion Leaders also reviewed 
the assessment to assist in contextualizing its use in practice. 
 
Results: The literature review produced 31 related articles and 235 concepts. From these concepts, organizational capacity experts 
identified 9 unique domains. Ultimately, a 20-item tool with 1-4 concepts assessing each domain was created. The internal vetting 
feedback demonstrated strong interrater agreement (IRA) across all 9 domains (96%) and strong support of concept relevance, 
clarity and alignment (content validity index (CVI) means of M = 3.71, 3.38 and 3.71 respectively). Two concepts required further 
revision based on IRA scores (“Financial Resources” and “Staff Implementation Supports”). Further, CVI calculations indicated that 
several concepts required minor revisions. No concepts were determined to require major revisions. Key Opinion Leaders 
recommended this assessment be incorporated into an adapted readiness evaluation. 
 
Conclusions: The content validity analysis revealed that there was a high level of agreement among raters across all content 
domains, and that the relevance, clarity, alignment and necessity of the concepts in each domain were largely validated. Overall, this 
process affirms that the preliminary self-assessment, rooted in organizational capacity and pharmacy practice, has content validity 
and should be incorporated into an adapted readiness assessment prior to undergoing Construct Validation. 
 
 
Introduction 
 
In 2013, health care costs attributed to the improper and unnecessary use of medicines exceeded $200 billion.1 This excess spend 
indicates a clear need for medication optimization services. A service such as comprehensive medication management (CMM) could 
fill this medication optimization need. CMM is a clinical service offered by pharmacists in a variety of settings including primary care 
clinics, community pharmacy and inpatient hospital environment. The goal of CMM is to optimize medication use, improve health 
outcomes, and reduce costs associated with medication-related problems. Unfortunately, at this time, there is not consistent 
application of the CMM intervention across the practice of pharmacy and limited evidence of impact on patient care.2–8  As a part of 
a larger ongoing study “Enhancing Performance in Primary Care Medical Practice through Implementation of Comprehensive 
Medication Management (CMM),” this project aims to address the problems with implementation of CMM in the primary care 
setting.2  
 
There are multiple compounding factors that result in an incomplete implementation of the CMM intervention in the primary care 
setting. These factors include lack of a common language around CMM processes of care, inconsistent delivery of the CMM 
intervention across the practice of pharmacy and lacking infrastructure requirements for the practice of CMM.3,4 Ongoing efforts by 
researchers in the parent study are working to address the need for a common language for CMM by developing a comprehensive 
process and language document. Meanwhile, others on the parent study are working on fidelity assessments to address the 
inconsistent delivery of CMM. This project aims to tackle the lacking infrastructure requirements for the practice of CMM by helping 
clinicians in primary care clinics understand which infrastructural elements are necessary for CMM implementation. Specifically, this 
study applied organizational capacity to the CMM model to examine those infrastructure needs. 
 
Organizational capacity is conceptualized as the characteristics that an organization needs in order to function and successfully 
implement innovations.9 At the organizational level there are two types of capacity: general capacity and innovation-specific 
capacity. General capacity refers to the overall functioning that is associated with the ability to implement or improve any 
innovation. 10 Innovation-specific capacity refers to the human, technical, and fiscal conditions which are necessary to successfully 
implement a particular innovation.10  Examples of organizational-level general capacity include leadership, organizational 
structure/management style, organizational climate and culture, resource availability, staff capacity, and external relationships. 
Examples of organizational-level innovation-specific capacity include fit between the organization and the intervention, 
administrative and other supports, buy in for the intervention, training and TA for the intervention, and evaluation capacity. This 
project set out to design an assessment around innovation-specific organizational capacity to assist primary care clinics in their 
implementation of CMM. 
 
Methods 
 
In order to design a unique assessment tool centered on innovation specific organization capacity, an informal literature search and 
expert input was utilized. Once the tool was drafted it was sent to a team of internal vetters and a panel of Key Opinion Leaders for 
review. Finally, the input provided by the Key Opinion Leaders and internal vetting team was used to revise and finalize the 
assessment. The work completed in this project was covered under IRB approval previously obtained for the parent study (IRB #16-
0485).  
 
Targeted Literature Review & Concept Consolidation 
 
In order to collect a comprehensive list of Organizational Capacity concepts, 
a targeted literature review was conducted. Key sources of information 
reviewed included the Practice Management Tool, Drivers Best Practices 
Assessment and the organizational capacity literature seen in Figure 1 to 
the right.11,12 The Practice Management Tool was developed by members of 
the parent study and served as a pharmacy centric source of information 
while the Driver’s Best Practices assessment was rooted in implementation 
science and provided an implementation science perspective on 
organizational capacity through their list of drivers.11,12 The purpose of 
conducting an informal review of the organizational capacity literature was 
to capture concepts not represented in our two targeted assessments. 
 
The informal literature search strategy, developed in conjunction with an organizational capacity expert, utilized complementary 
approaches to ensure there would be comprehensive collection of concepts from the organizational capacity literature. To start, the 
organizational capacity expert provided key organizational capacity building models included in an unpublished literature review for 
initial examination. Core concepts were pulled from this body of literature and a reverse snowball method was utilized via Web of 
Science to identify more recent publications that have since cited these landmark models. Second, a general search of the literature 
was conducted in PubMed and Google Scholar. Utilizing a pre-determined set of inclusion and exclusion criteria, outlined in Table 1 
below, articles were selected for full review. 
 
Inclusion and exclusion criteria used in literature search 
Inclusion Criteria Exclusion Criteria 
 
• Title or abstract included “organizational capacity,” “innovation 
specific capacity,” “innovation capacity” or “organizational 
framework” 
• Published in English with full text available 
• Peer reviewed 
 
• Did not detail framework or concepts 
• Described general capacity 
• Published prior to 1998 
Table 1. Inclusion and exclusion criteria for literature review 
 
As concepts were pulled from the Drivers Best Practices Assessment, the Practice Management Tool and the organizational capacity 
literature and individual concepts were recorded and cataloged by their source.11,12 Concepts that were individually assessed in each 
of the two existing tools or independently described in the organizational capacity literature were pulled for further evaluation. 
Concepts that were not described, not assessed with at least one item or merely mentioned in organizational capacity models were 
excluded from the extraction process. Organizational capacity experts then assisted in review of extracted concepts to help map 
concepts to thematic domains. Through this expert review process redundant concepts were eliminated and the remaining concepts 
were organized into thematic domains. 
 
Assessment Design 
 
Utilizing the finalized list of concepts identified from the literature search, a minimum of one question per concept was either 
adapted from existing assessments or originally created by the research team. The questions were then arranged by thematic 
domain into a complete survey. Each question was assessed via a seven point Linkert scale which asked respondents the extent to 
which they agree with the statement made in the question. Answer choices ranged from “Strongly Disagree” to “Strongly Agree.” 
The draft survey was compiled into a Microsoft word document for ease of use during the content validation process. 
 
Figure 1. Sources of information for concept collection 
Content Validation 
 
To establish content validity, a cohort of seven internal vetters, including clinical pharmacists and implementation scientists, was 
assembled. Seven internal vetters were selected to meet the number of reviewers recommended by Rubio et al. for utilization of the 
less conservative approach for analysis of interrater agreement.13 The assessment was sent out, with instructions, via email to the 
internal vetting team who were given two weeks to complete the process. Reminder emails were sent out one week into the vetting 
period to increase the response rate. 
 
The internal reviewers were asked to evaluate the questions for each concept in the draft assessment by three criteria from Rubio et 
al: 1) representativeness of the content domain; 2) clarity of the concept; 3) alignment of the measure to the concept.13 Each of 
these three criteria were rated on a scale of 1-4, where higher scores indicated better alignment with the assessed criteria. The 
primary endpoint of this validation study was to determine the interrater agreement and concept validation index for each of the 
concepts. Per Rubio et al, interrater agreement was taken as the number of vetters who “agreed” with the measure divided by the 
total number of internal vetters. Vetters were classified as having agreed with the existing measure if they selected either of the top 
two categories (numerically either a three or a four). For example, if Concept X had three vetters select “Representative,” three 
vetters select “Minor revisions needed to be representative” and one vetter mark that the concept as “Not representative,” the 
interrater agreement would be equal to six out of seven or 86% agreement. Conversely, the content validation index was calculated 
as a simple mean, where respondents’ ratings were averaged for every concept by the three different criteria. Concepts with scores 
above 3.5 were considered valid, concepts with scores below 3.5 but greater than 2.5 were considered to be valid with minor 
revisions and scores below 2.5 were considered invalid and requiring major revisions. As a secondary endpoint of interest, internal 
vetters were also asked if they felt each of the concepts were “vital” to the practice of CMM and given the opportunity to provide 
open ended feedback, comments and suggestions for edits throughout. In analysis of which concepts were “vital” to the practice of 
CMM, the number of respondents who answered that the concept was indeed vital was divided by the total number of respondents. 
An example of the vetting assessment completed by internal vetters is provided in Figure 2 below. 
 
FEEDBACK FORM: Domain Name 
 
Representativeness of Items Clarify of Items Alignment of Items with Concept 
Concept vital to 
CMM delivery 
Comments 
N
ot 
representative  
M
ajor revisions 
needed to be 
representative  
M
inor revisions 
needed to be 
representative  
Representative  
N
ot clear  
M
ajor revisions 
needed to be 
clear  
M
inor revisions 
needed to be 
clear  
Clear  
Should not be 
included as 
m
easuring this 
concept  
M
ajor revisions 
needed  
M
inor revisions 
needed  
M
easures this 
factor w
ell  
N
O
T necessary 
to CM
M
 delivery  
Vital for the 
delivery of CM
M
 
 
Concept ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
 
Figure 2. Example internal vetting questionnaire to be completed for each concept 
 
Upon return of internal vetting feedback individual responses were aggregated into a single Microsoft Excel spreadsheet. First, we 
assessed the responses for interrater agreement to determine the extent to which the experts are reliable in their ratings for 
representativeness, clarity and alignment. The content validity index mean was then calculated, according to the adapted Rubio et 
al. methodology described above, for each concept to determine if the included items were representative, clear and aligned 
appropriately.13 Scores below 80% for interrater agreement and 3.5 for content validation index means were pulled for further 
revision and editing as suggested in Rubio et al.13 
 
Key Opinion Leader Review 
 
As a complement to the detailed internal vetting review process, a panel of outside key opinion leaders were brought into discuss 
the utility of the assessment and provide insight on how it would be best distributed. The group reviewed the assessment’s 
placement among existing tools currently available in the field. At the request of this panel, concepts contained in the newly created 
organizational capacity assessment were stratified against concepts contained in the Practice Management Tool and Driver’s Best 
Practices Assessment.11,12 Concepts in the Practice Management Tool and Driver’s Best Practice Assessment were pulled during the 
original concept extraction and filed under their original domains. In order to demonstrate how the domains from the existing tools 
aligned with the new assessment, a crosswalk which aligned similar domains and concepts was made with the domains and concepts 
from each of the three tools and assessments. Where domains or concepts did not align they were highlighted in yellow and pulled 
to the bottom of the crosswalk graphic. This crosswalk along with the draft assessment were shared with the Key Opinion Leaders 
Review panel in order to discuss the best fit for the project. 
 
 
 
Results 
 
Targeted Literature Review & Concept Consolidation 
 
In addition to the Practice Management Tool and Driver’s Best Practices Assessment, 31 organizational capacity articles were 
selected for the full review and concept extraction process following the initial identification of over 200 articles. From this body of 
literature, 235 concepts were extracted in total with 78 from the Practice Management Tool, 27 from the Driver’s Best Practices 
Assessment and 130 from the organizational capacity literature.11,12 
 
Assessment Design 
 
These 235 concepts were collapsed into 9 unique concepts and organized into 5 thematic domains. For each concept, a concise 
definition was created to contextualize the concepts within the CMM intervention, the domains, concepts and definitions can be 
seen in Table 2 below. These 9 concepts were then used to design a draft assessment that contained a total of 20 questions with 1-4 
questions assessing each concept. The assessment itself was organized by domain then concept, with questions within the concepts 
following an intentional stepwise order when applicable. The original draft assessment can be seen in Appendix A. 
 
Concepts included in assessment ordered by domain 
Domain Concept Definition 
Resources 
Space Resources Adequate physical space to provide CMM. 
Technology & Information Resources Available software and electronic tools to document patient encounters and care as part of CMM. Also includes access to clinical information and evidence based practices. 
Financial Resources Adequate finances to support CMM services. 
Workforce Capacity 
Staff Attributes Staff have appropriate background education and training needed to provide CMM. There is enough time dedicated to carry out CMM. 
Staff Implementation Support There are hiring and training processes in place to support staff delivering CMM. 
Buy In Motivation from Staff 
Staff, including the pharmacists conducting CMM and the support staff, are motivated to deliver 
CMM. 
Motivation from Leadership CMM is a priority for the organization and has leadership support of CMM. 
Organizational Environment Internal Processes "Wrap around" processes, such as patient identification/outreach are in place and integrated into clinic workflow. 
Learning from Experience Data Decision Support Tool A routine process by which clinic level data collected by the data decision support tool is extracted, evaluated and utilized to improve CMM delivery. 
Table 2. Definitions for each of the unique concepts within their thematic domain 
 
Content Validation 
 
The internal vetting resulted in a 100% response rate from the group of seven internal vetters. Overall, the internal vetting team was 
consistent in their rating of individual concept as demonstrated by the very high interrater agreement (IRA) of 96%. IRA across 
criteria was also strong with an IRA of 92%, 84% and 93% for concept representativeness, clarity and alignment, respectively. The 
IRA scores for “Financial Resources” representativeness and clarity came in below the pre-determined cut off at 71% for each 
criterion respectively, thus “Financial Resources” was identified as an area for further revision. 
 
The content validation index (CVI) mean across all criteria came to 3.59  out of 4 and was further broken down by concept and 
criteria as seen in Table 3 below. As seen below, no concept fell below the cut off of 2.5 which would require major revisions to 
meet content validation; however, several concepts scored between 2.5 and 3.5 indicating a need for minor revisions to meet 
content validation standards. Concepts requiring minor revisions, based on their CVI, included Financial Resources, Staff Attributes, 
Staff Implementation Support, Motivation from Staff, Motivation from Leadership and Internal Processes. 
 
Content validation index score by concept 
Domain Concept Representativeness Clarity Alignment 
Resources 
Space Resources 4.00 3.71 4.00 
Technology & Information Resources 3.86 3.57 3.71 
Financial Resources 3.43 2.71 3.57 
Workforce Capacity Staff Attributes 3.57 3.29 3.71 
Staff Implementation Support 3.57 3.14 3.43 
Buy In Motivation from Staff 3.71 3.43 3.57 
Motivation from Leadership 3.71 3.43 3.57 
Organizational Environment Internal Processes 3.86 3.43 4.00 
Learning from Experience Data Decision Support Tool 3.71 3.71 3.86 
Table 3. Content validation index scores for each concept sorted by criteria 
 
Finally, the internal vetting team was asked to determine if they felt that each of the individual concepts assessed was “vital” to the 
practice of CMM. Since the question was dichotomous, answers were not averaged; rather the number of respondents who agreed 
the concept was vital to the practice of CMM was divided by the number of respondents total and given as a percentage. Notably, 
almost all concepts were considered vital to the practice of CMM by the internal vetting team, thus obtaining 100% agreement, with 
the exception of three: “Staff Implementation Support,” “Internal Processes” and “Data Decision Support Tool,” which scored at 
71%, 86% and 71% agreement, respectively. 
 
Key Opinion Leader Review 
 
The input provided during the Key Opinion Leader Review indicated that this assessment best fit within a larger assessment of 
readiness that the parent study was already in the process of developing at the time. Readiness consists of three main components: 
innovation specific capacity, motivation and general capacity as outlined in Figure 3 below. During the Key Opinion Leader Review, 
experts discussed how organizational capacity is differentiated from readiness, which includes both capacity and motivation to 
implement a change (at the organizational and other levels). Overall it was decided that innovation specific capacity felt well within 
this already existing framework and could be applied to ongoing efforts in this area in a timely manner.  
 
Figure 3. Hierarchy of readiness and its three main components 
 
The content of this assessment, as determined by Key Opinion Leaders, largely covered the innovation specific capacity portion of 
the readiness assessment and covered portions of the motivation assessment as well. The result of this review indicated the need 
for the addition of three new concepts: “Champion,” “Team” and “External Relationships.” The addition of the champion and team 
concepts would allow for this assessment to more fully cover the motivation aspect of readiness while the addition of the external 
relationship concept allowed the assessment to comprehensively cover missing aspects of innovation specific capacity. 
 
Discussion 
 
Analysis of Key Findings 
 
Key findings from this project include the development of a 20-item assessment based on 9 unique concepts organized into 5 
domains. The length and simplicity of this assessment allow for its completion in the practice setting as a self-assessment for 
Readiness	
Innova,on	Speciﬁc	
Capacity	 Mo,va,on	 General	Capacity	
clinicians or clinic managers working to implement or improve their CMM offerings to evaluate their operations at various stages of 
innovation implementation to track progress or identified barriers to complete implementation. The ability to utilize this assessment 
independently in the practice setting is an advantage over other assessments that require on site coaching or expert guidance, such 
as the Practice Management Tool and Driver’s Best Practices Assessment.11,12   
 
Reviewers largely agreed that all concepts assessed were vital to the practice of CMM with the exception of “Staff Implementation 
Support,” “Internal Processes” and “Data Decision Support Tool” which were not considered vital by all reviewers. Notably, even 
concepts that were well understood such as the “Internal Processes” and “Data Decision Support Tool” were not considered vital to 
the practice of CMM. Thus, even though internal vetting team members clearly understood the concept items and believed they 
aligned well with the overall domain, they did not report these concepts as being required for successful implementation. Given that 
the internal reviewers were either current pharmacists practicing CMM or implementation scientists, this suggests a disconnect 
between what is done in the practice, and what should be done in practice in order to be successful. Comments from the internal 
vetting team suggested that while some of the organizational capacity concepts might be “nice to have,” they were “not necessary 
for simple implementation,” raising the concern that some practitioners do not understand the need for full implementation support 
in order to successfully adopt an innovation. 
 
The key findings from the Key Opinion Leader review revealed the need to incorporate the assessment within an adapted readiness 
assessment. Three concepts were added to the assessment in order to meet this need. Two of these concepts were added to fill out 
the assessment of motivation, a key aspect of readiness. While the other added concept, “External Relationships” closely matches a 
concept that was previously removed from the original draft during the concept consolidation process. The “External Relationships” 
concept was removed by researchers prior to assessment completion because it assessed aspects of the practice that were likely 
outside of a single provider’s control and this was felt to be out of scope for a simple organizational capacity assessment. The 
conecept of “External Relationships” may however be included in a later readiness assessment, as readiness assesses multiple levels 
of capacity and does require this higher-level assessment again be included. Based on these recommendations and the insights of 
key opinion leaders, the next step for this assessment will be to incorporate it into a larger adapted readiness assessment which will 
undergo larger pilot studies which can establish construct validity for the overall assessment.  
 
Limitations 
 
The informal process utilized for the initial literature review introduced the potential for selection bias by researchers and may have 
limited the scope and diversity of organizational capacity frameworks reviewed. Input from an organizational capacity expert and 
utilization of an unpublished, yet comprehensive, literature review attempted to correct for this potential bias by ensuring the 
literature findings were representative of the field. 
 
Additionally, the Rubio et al. methodology was adapted to streamline the process for the internal vetting team. By asking internal 
vetters to provide feedback at the concept level, rather than for each individual item, some original data or points of interest may 
have been lost among the aggregate average. However, by allowing internal vetters to provide open ended feedback on each 
question and section this limitation may also have been minimized.  
 
Innovation & Comparison to Existing Literature 
 
This project was innovative in its application of organizational capacity to the CMM model of care. Innovation specific capacity is an 
important component of readiness and has previously not been well studied in the field of pharmacy, as indicated by the paucity of 
literature on the topic.14 As the first to perform an in-depth study and assessment design around organizational capacity of CMM, 
this project represents a new addition to the fields of pharmacy practice and organizational capacity research. 
 
Implications of Findings 
 
Overall this project developed and validated the content of a CMM specific organization capacity assessment and uncovered the 
need to incorporate this work into an adapted readiness assessment prior to moving forward with further validation studies 
including a construct and criterion validation processes. Once this consolidated assessment completes the process of validation, it 
will serve as a well validated tool for practitioners in the primary care setting looking to implement or improve upon their CMM 
services. The finalized tool will help clinicians understand areas for growth and identify missing components necessary for complete 
and successful implementation of their CMM service. 
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Appendix A 
CMM Organizational Capacity Assessment 
 
This assessment is intended to be completed by the lead pharmacist or pharmacist clinic manager and serves as a 
preliminary needs assessment to guide implementation and improvement of CMM in the primary care setting. The 
results of this simple assessment should direct the pharmacist to more specific tools to improve practice management, 
such as the “Practice Management Assessment Tool”.  This pre-assessment was designed following a review of the 
literature on organizational capacity and implementation science. The tool was also reviewed to ensure its alignment 
with the recently developed CMM “Practice Management Tool.” This assessment is organized according to the following 
five domains. Each domain is further broken down into concept(s).  
 
A. RESOURCES    
I. Space Resources - Adequate physical space to provide CMM.  
II. Technology & Information Resources - Available software and electronic tools to document patient encounters and 
care as part of CMM. Also includes access to clinical information and evidence based practices. 
III. Financial Resources - Adequate finances to support CMM services. 
B. WORKFORCE CAPACITY 
I. Workforce Attributes - Staff have appropriate background education and training needed to provide CMM. There 
is enough time dedicated to carry out CMM. 
II. Workforce Implementation Support - There are hiring and training processes in place to support staff delivering 
CMM. 
C. BUY IN  
I. Motivation from Staff - Staff, including the pharmacists conducting CMM and the support staff, are motivated to 
deliver CMM. 
II. Motivation from Leadership - CMM is a priority for the organization and has leadership support of CMM. 
D. ORGANIZATIONAL ENVIRONMENT 
I. Internal Processes - "Wrap around" processes, such as patient identification/outreach are in place and integrated 
into clinic workflow. 
E. LEARNING FROM EXPERIENCE 
I. Data Decision Support Process - A routine process by which clinic level data collected by the data decision support 
tool is extracted, evaluated and utilized to improve CMM delivery. 
 
Space Resources 
 
1. My site (the location where CMM is delivered) has adequate space available for providing quality patient care. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
Technology & Information Resources 
 
2. The CMM pharmacist(s) have an electronic system to document patient encounters.  
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
3. The CMM pharmacist(s) and team have access to patient medical records. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
4. The CMM pharmacist(s) and team have access to informational resources necessary to carry out CMM (e.g., current clinical 
guidelines, CMM Common Language Document). 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
 
Financial Resources 
 
5. Financial resources are available to support CMM delivery at my site. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
Workforce Attributes 
 
6. The CMM pharmacist(s) at my site have the knowledge and skills necessary to deliver CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
7. There is a sufficient number of staff to deliver CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
Workforce Implementation Support 
 
8. There is a process in place to train the pharmacist(s) and team on the CMM patient care process. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
9. There is a process in place to replace the CMM pharmacist(s) and team member in the case of a vacancy or staff shortage. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
Motivation from Staff 
 
10. The CMM pharmacist(s) are committed to implementing CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
11. The other team members at the site support the implementation of CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
Motivation from Leadership 
 
12. Leadership at my organization actively supports the implementation of CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
13. The leadership allocates a sufficient amount of time for CMM pharmacist(s) and team to deliver CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
14. CMM is a priority for the leadership in my organization. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
Internal Processes 
 
15. There is a systematic process for collaborating with other healthcare team members when delivering CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
16. There is a process to identify patients eligible for CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
17. There is a process to schedule patients for CMM appointments.  
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
18. CMM can be integrated into the site's workflow. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
Data Decision Support Process 
 
19. My site has a process for collecting data for CMM quality improvement.  
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
20. My site has a process for using the data collected to improve CMM. 
Strongly Disagree Disagree Slightly Disagree Slightly Agree Agree Strongly Agree 
1 2 3 4 5 6 
 
 
